MAOB and early-onset autosomal dominant Alzheimer disease: Previously explored for Parkinson’s disease in in vitro model systems, 5MeO demonstrated potent neuroprotective effects, strong antioxidant properties, and significant inhibition of MAO-B, a key enzyme implicated in both Parkinson’s and Alzheimer’s disease.